Product Applications
1. inPharmaceutical Industry.Sicut medicamentis medicamentis.
2. in theCampus cosmeticus,in skincare products usus erit.
3. in theCibus et Potus Industry.Ut a supplementum. Addi potest ad cibis utilitatibus sicut vectes sanitatis vel puritate quatit.
4. InNutraceutical.Adhibetur in formula productorum nutraceuticorum.
Effectus
1. facilisis Actio
— Apigenin has antioxidant validas possessiones. Liberum radicalium radicalium in corpore evolare potest, ut species oxygenii reciproci (ROS). Hoc iuvat ad praecavendam oxidativa damna cellulis et biomoleculis sicut DNA, servo, et lipides.
2. Effectus inflammationis Anti-
- Prohibet productionem mediatorum inflammationis. Exempli gratia, supprimere potest activationem quorundam cytokinorum inflammatoriis sicut interleukin - 6 (IL - 6) et tumor necrosis factoris - alpha (TNF - α).
3. Anticancer Potential
— Apigenin apoptosin (programma cell mortem) in cellulis cancri inducere potest. Potest etiam incrementum et multiplicationem cellularum cancri prohibendo impedire progressionem cycli cellularum. Nonnulla studia suam efficaciam contra carcinomata quaedam, ut cancer pectus, et cancer prostatae demonstraverunt.
4. Neuroprotective Function
— Neuronem ab damno tueri potest. Exempli gratia, reducere toxicitatem excitatoriam amino acida in cerebro causata. Hoc prodesse potest in morbis neurodegenerativis sicut Alzheimer's et Parkinson.
5. Cardiovasculares Beneficia
- Apigenin ut adiuvet in reducendo sanguinem pressura. Etiam munus endotheliale emendare potest, quod magni momenti est ad conservandas venas sangui- nes et morbos cardiovasculares prohibendos.
Testimonium Analysis
| Product Name | Apigenin Pulvis | OPIFICIUM Date | 2024.6.10 | |
| quantitas | 500KG | Analysis Date | 2024.6.17 | |
| Batch No. | BF-240610 | Exitus Date | 2026.6.9 | |
| Items | Specifications | Proventus | Methodus | |
| Pars Plantae | totum herba | Comforms | / | |
| Patria Origin | China | Comforms | / | |
| Assay | 98% | 98.2% | / | |
| Aspectus | Lux YellowPulvis | Comforms | GJ-QCS-108 | |
| Odor&Sapor | Proprium | Comforms | GB/T 5492-2008 | |
| Magnitudo particula | >95.0%per80 mesh | Comforms | GB/T 5507-2008 | |
| Damnum in Siccatio | ≤.5.0% | 2.72% | GB/T 14769-1993 | |
| Cinis Content | ≤.2.0% | 0.07% | AOAC 942.05,18th | |
| Totalis Metal | ≤10.0ppm | Comforms | USP <231>, methodus | |
| Pb | <2.0ppm | Comforms | AOAC 986.15,18th | |
| As | <1.0ppm | Comforms | AOAC 986.15,18th | |
| Hg | <0.5ppm | Comforms | AOAC 971.21,18th | |
| Cd | <1.0ppm | Comforms | / | |
| Microbiological Test |
| |||
| Totalis comitis Plate | <1000cfu/g* | Comformae | AOAC990.12,18th | |
| Fermentum & Mold | <100cfu/g | Comformae | FDA (BAM) Chapter 18,8th Ed. | |
| E.Coli | Negative | Negative | AOAC997,11,18th | |
| Salmonella | Negative | Negative | FDA(BAM) Chapter 5,8th Ed | |
| Packaetas | In sacculo plastico intus et aluminium claua folliculi foris referta. | |||
| Repono | Condite in loco frigido et sicco, abstinete a luce et calore forti. | |||
| Vita fasciae | biennio rite conditum. | |||
| conclusio | Sample secundum quid. | |||
Detail Image
